The CRI-ICRF Clinic and Laboratory Integration Program (CLIP) Grant to Fund Promising Immunotherapy Research in Israel Is Awarded to Yifat Merbl, PhD, of the Weizmann Institute of Science
The free event, moderated by Ana Patricia Gámez, shared the latest promising research by top immunotherapy experts, patient stories, and clinical trial updates
CRI to give the 2022 William B . Coley Award for Distinguished Research in Basic and Tumor Immunology to celebrate molecular and mechanistic studies on gasdermins that revealed their critical role in a highly immunogenic form of cell death called pyroptosis, with preclinical studies showing significant promise to help more cancer patients respond to immunotherapy.
The free online event will connect cancer patients and caregivers with the latest promising research findings shared by top immunotherapy experts, patient success stories, and clinical trial updates, on September 22, 2022, at 2 p.m. ET
Six U.S. scientists have been awarded $1.25 million each over 5 years to conduct high-risk, high-reward cancer immunology research with potential to transform cancer treatment
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
Dr. Benjamin Vincent recaps highlights from Day 4 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference, covering cancer vaccines and innovative technologies to study tumor immunity.
Dr. E. John Wherry dicusses cell therapies and the cancer ecosystem during Day 3 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22).